Samit Hirawat Bristol Myers Squibb CO (BMY) insider trading activity

Samit Hirawat is EVP,Chief Med.Offr.,Drug Dev. of BRISTOL MYERS SQUIBB CO. Currently has a direct ownership of 60,279 shares of BMY, which is worth approximately $2.48 Million. The most recent transaction as insider was on Mar 10, 2024, when has been sold 11,705 shares (Common Stock, $0.10 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 60.3K

27.59% 3M change

41.25% 12M change

Total Value Held $2.48 Million

Samit Hirawat Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 10 2024	SELL Other acquisition or disposition	-	11,705 Reduced 14.32%	70,053 Common Stock, $0.10 pa...
Mar 10 2024	SELL Payment of exercise price or tax liability	$734,179 $53.79 p/Share	13,649 Reduced 18.46%	60,279 Common Stock, $0.10 pa...
Mar 10 2024	BUY Exercise of conversion of derivative security	-	38,388 Added 32.36%	80,256 Common Stock, $0.10 pa...
Jul 01 2023	SELL Payment of exercise price or tax liability	$306,128 $63.95 p/Share	4,787 Reduced 9.2%	47,245 Common Stock, $0.10 pa...
Jul 01 2023	BUY Exercise of conversion of derivative security	-	9,357 Added 15.24%	52,032 Common Stock, $0.10 pa...
Mar 10 2023	SELL Payment of exercise price or tax liability	$1,471,575 $65.71 p/Share	22,395 Reduced 34.42%	42,675 Common Stock, $0.10 pa...
Mar 10 2023	BUY Exercise of conversion of derivative security	-	38,978 Added 41.91%	54,035 Common Stock, $0.10 pa...

Mar 10 2023	BUY Other acquisition or disposition	-	4,800 Added 7.75%	57,104 Common Stock, $0.10 pa...
Jul 01 2022	SELL Payment of exercise price or tax liability	$367,756 $76.84 p/Share	4,786 Reduced 18.35%	21,292 Common Stock, $0.10 pa...
Jul 01 2022	BUY Exercise of conversion of derivative security	-	9,356 Added 26.4%	26,078 Common Stock, $0.10 pa...
Mar 10 2022	SELL Payment of exercise price or tax liability	$356,126 $68.42 p/Share	5,205 Reduced 23.74%	16,722 Common Stock, $0.10 pa...
Mar 10 2022	BUY Other acquisition or disposition	-	1,101 Added 5.34%	19,501 Common Stock, $0.10 pa...
Mar 10 2022	BUY Exercise of conversion of derivative security	-	9,074 Added 32.38%	18,953 Common Stock, $0.10 pa...
Jul 01 2021	SELL Payment of exercise price or tax liability	$318,556 $66.56 p/Share	4,786 Reduced 28.94%	11,752 Common Stock, $0.10 pa...
Jul 01 2021	BUY Exercise of conversion of derivative security	-	9,356 Added 36.13%	16,538 Common Stock, $0.10 pa...
Mar 10 2021	SELL Payment of exercise price or tax liability	$120,520 $60.93 p/Share	1,978 Reduced 21.59%	7,182 Common Stock, $0.10 pa...
Mar 10 2021	BUY Other acquisition or disposition	-	78 Added 0.84%	9,160 Common Stock, $0.10 pa...
Mar 10 2021	BUY Exercise of conversion of derivative security	-	4,189 Added 31.57%	9,082 Common Stock, $0.10 pa...
Jul 01 2020	SELL Payment of exercise price or tax liability	$265,236 $59.43 p/Share	4,463 Reduced 47.7%	4,893 Common Stock, $0.10 pa...
Jul 01 2020	BUY Exercise of conversion of derivative security	-	9,356 Added 50.0%	9,356 Common Stock, $0.10 pa...

Samit Hirawat

EVP,Chief Med.Offr.,Drug Dev.

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMY shares.

Notify only if

Value

Insider Trading

Get notified when an Bristol Myers Squibb CO insider buys or sells BMY shares.

Notify only if

Operation

Value

Type

News

Receive news related to BRISTOL MYERS SQUIBB CO

Track Activities on BMY

Account